Finances
VICTOR Trial Results on VERQUVO in Heart Failure
Heart Failure remains a significant health challenge, particularly in patients with chronic conditions like heart failure with reduced ejection fraction (HFrEF). This article delves into the outcomes of the VICTOR trial, which assessed the efficacy of VERQUVO® (vericiguat) in these patients. Despite not achieving statistical significance for its primary endpoint, Read more…